XS
BIOR

XR Securities’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

XR Securities’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46
Closed -$14K – 558
2021
Q4 		$14K Buy
+46
New +$33K ﹤0.01% 396

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return

XR Securities's BIOR Position: Q4 2022 in Review

XR Securities sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2022, closing a stake of 43 shares — an estimated $5K sold.

XR Securities first reported a position in BIOR in Q3 2022 and held it in 1 quarter. The position peaked at $5K in Q3 2022. 42 funds tracked by Wall St. Rank hold BIOR as of Q4 2022.

  • XR Securities reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • XR Securities sold 43 Biora Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $5K.
  • XR Securities first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • XR Securities's Biora Therapeutics, Inc. Common Stock position peaked at $5K in Q3 2022.
  • 42 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2022.

Based on XR Securities's 13F filing for Q4 2022, filed 3 Jan 2023.